(See September 2008 report #A125, “Ablation Technologies Worldwide Market, 2008-2017,” from MedMarket Diligence, LLC. May be purchased online.)
Energy-based therapies generate sales of $13 billion in the United States alone, with probably another $12 billion in other developed markets worldwide. This represents around 13% of the total medical device market, and it is growing at 11% [...]
The revenues to be had from the clinical management of obesity, whether derived from pharmaceutical or device sales, are forecast to see double-digit growth through 2015. Although revenues have been dampened by the FDA’s negative reaction to Sanofi-Aventis’ application for rimonabant, there are other drug compounds in late stages of testing which may prove to [...]
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
(From the September 2007 issue of MedMarkets)
Drawing upon the clinical and technology sectors we have addressed in MedMarkets and the Market and Technology Reports of MedMarket Diligence, we have previously identified a number of areas where we see substantial growth in medical technology markets. In our white paper, High Growth Medical Technologies, we note those [...]
We analyze medical device markets and, by natural extention, markets encompassing devices or simply competing with them. We identify a specific disease or disorder, characterize its patient population, current and emerging trends in treatment and then characterize the markets for the products used. We may alternatively focus on an organ system (e.g., ophthalmology or a [...]
The current worldwide value of drugs and devices for the treatment of obesity stands at $750 million, representing a minor share of the combined potential market expected for these products over the next decade as rates of obesity incidence and prevalence surge and as recognition of its healthcare cost drives development of effective [...]
Surgical wounds are projected to increase in number at an annual rate of 3%, but overall the severity and size of surgical wounds will continue to decrease over the next five years as a result of the continuing trend toward minimally invasive surgery.
Surgical procedures generate a large number of uncomplicated acute wounds with uneventful healing, [...]
The worldwide market for obesity drugs represents an extremely attractive opportunity, even more so now that Sanofi-Aventis rimonabant has failed to gain FDA approval.
A surprise to no one, the incidence of obesity and morbid obesity is on the rise, pushing an aggregate prevalence in excess of 300 million patients globally, and outpaced in growth only [...]
(The GERD patient population is a largely untapped surgical market; see chart entitled, “Total Potential Market for Endoscopic GERD Therapies”)
Physicians from UT Southwestern Medical Center and engineers from UT Arlington have collaborated to develop a new technology for detecting the occurrence of heartburn and gastroesophageal reflux disease (GERD). Presented in May at the Digestive Disease [...]